Default company panoramic image


Innovative, rapid, daytime urine test to diagnose & manage obstructive sleep apnea that will replace overnight sleep lab studies.

  • Stage Product In Development
  • Industry Medical Devices and Equipment
  • Location Annapolis, MD, USA
  • Currency USD
  • Founded January 2012
  • Employees 3
  • Website

Company Summary

Daytime urine biomarker home test allows easy, inexpensive, accurate diagnosis of Obstructive Sleep Apnea, with 100% sensitivity & 96.5% specificity. This is the first & only test to enable ongoing measurement of therapy response (i.e recurring revenue stream). Initially targeting pediatric OSA, where current diagnostic tests are expensive/difficult, it will also be developed to diagnose adult OSA. 1% share of US market equals $76MM in revenue.


  • Default avatar
    Michael J. Thomas
    Co-Founder, CEO

    Former CEO of iSonea Ltd (ASX:ISN), a publicly traded global, mobile health app developer and medical device manufacturer in the respiratory disease market. He is a member of the Board of Directors for Circadiance LLC, a specialty CPAP mask manufacturer. He is also the President and CEO of Appian Partners, a medical devices and healthcare services consulting firm. Earlier in his career, Thomas was President and CEO of Sleep Solutions, a VC-backed

  • Default avatar
    Roland Valdes, Ph.D.
    Chief Science Officer, Co-Founder

    Dr. Valdes is Senior Vice-Chairman of the Department of Pathology and Laboratory Medicine at the University of Louisville. He is also Professor of Biochemistry and Molecular Biology and holds the appointment of Distinguished University Scholar. Dr. Valdes serves as Director of Clinical Chemistry and Toxicology and as Director of the Postdoctoral Fellowship Program in Clinical Chemistry and Laboratory Medicine in the Department of Pathology. Dr. V

  • Default avatar
    Mark Linder, Ph.D.

    Dr. Linder is Associate Professor of the Department of Pathology and Laboratory Medicine at the University of Louisville. He is Assistant Director of Clinical Chemistry and Toxicology at the University of Louisville Hospital. As the Senior V.P. for Operations for PGXL Laboratories and PGXL Technologies, he oversees clinical studies conducted by the companies and is responsible for the operation of the CLIA lab. Linder is a thought leader in the n

  • Default avatar
    Tracey Dodenhoff
    VP. Business Development, Co-Founder

    An entrepreneurial leader driven by value creation. Tracey specializes in product commercialization and new market initiatives. She is the Founding Director of the Center for Research Innovation (CRI), an exciting new venture focusing on increasing commercialization activity from research initiatives. Tracey leads the translation of innovations into tangible commercial successes. She is the founder of Vanguard Technologies, LLC, a commercializat


  • Default avatar
    Wilson Sonsini Goodrich Rosati
    Default avatar
    Lombardo Wagner